SYN logo

Synthetic Biologics (SYN) Operating Expenses

Annual Operating Expenses

$14.27 M
+$4.11 M+40.49%

December 31, 2021

Summary

Performance

1-Year Change

+40.49%

3-Year Change

-18.76%

5-Year Change

-45.62%

15-Year Change

-45.62%

SYN Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$40.98 M
SYN annual total operating expenses is currently -65.17% below its historical high of $40.98 million

3-Year Low

$14.27 M
SYN annual total operating expenses is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
SYN previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
SYN next annual earnings announcement has not yet been scheduled

OtherSYNexpensesmetrics:

Annual Total Expenses

$14.27 M
SYN annual total expenses is $14.27 million

Annual Interest Expense

-
SYN annual interest expense value is unknown

Annual Income Tax

-
SYN annual income tax value is unknown

Annual Cost Of Goods Sold

-
SYN annual cost of goods sold value is unknown

Quarterly Operating Expenses

$4.99 M
+$733.00 K+17.24%

June 30, 2022

Summary

Performance

3-Month Change

+17.24%

1-Year Change

+55.93%

3-Year Change

+37.03%

5-Year Change

-23.01%

SYN Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.89 M
SYN quarterly total operating expenses is currently -58.06% below its historical high of $11.89 million

3-Year Low

$4.25 M
SYN quarterly total operating expenses is currently +17.24% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
SYN previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
SYN next earnings announcement has not yet been scheduled

OtherSYNexpensesmetrics:

Quarterly Total Expenses

$4.99 M
SYN quarterly total expenses is $4.99 million

Quarterly Interest Expense

-
SYN quarterly interest expense value is unknown

Quarterly Income Tax

-
SYN quarterly income tax value is unknown

Quarterly Cost Of Goods Sold

-
SYN quarterly cost of goods sold value is unknown

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$14.27 M
SYN annual total operating expenses is $14.27 million

Annual SGA

-
SYN annual SGA value is unknown

Annual D&A

-
SYN annual depreciation & amortization value is unknown

SYN Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+40.5%+55.9%
3 y3 years-18.8%+37.0%
5 y5 years-45.6%-23.0%

SYN Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-5.3%-14.7%
5 y5-year-8.9%-28.8%-5.3%-57.7%
alltimeall time-65.2%-90.8%-58.1%-94.0%

Synthetic Biologics Operating Expenses History

DateAnnualQuarterly
Jun 2022
-
$4.99 M(+17.2%)
Mar 2022
-
$4.25 M(-19.2%)
Dec 2021
$14.27 M(+40.5%)
$5.26 M(+60.8%)
Sep 2021
-
$3.27 M(+2.4%)
Jun 2021
-
$3.20 M(+26.0%)
Mar 2021
-
$2.54 M(+19.0%)
Dec 2020
$10.16 M(-35.1%)
$2.13 M(+1.0%)
Sep 2020
-
$2.11 M(-26.9%)
Jun 2020
-
$2.89 M(-4.6%)
Mar 2020
-
$3.03 M(-5.7%)
Dec 2019
$15.66 M(-10.9%)
$3.21 M(-38.8%)
Sep 2019
-
$5.24 M(+44.1%)
Jun 2019
-
$3.64 M(+1.8%)
Mar 2019
-
$3.57 M(+9.6%)
Dec 2018
$17.57 M(-33.1%)
$3.26 M(-24.6%)
Sep 2018
-
$4.32 M(-13.7%)
Jun 2018
-
$5.00 M(+0.3%)
Mar 2018
-
$4.99 M(-13.7%)
Dec 2017
$26.25 M(-33.1%)
$5.78 M(-1.0%)
Sep 2017
-
$5.84 M(-9.8%)
Jun 2017
-
$6.47 M(-20.5%)
Mar 2017
-
$8.15 M(-20.1%)
Dec 2016
$39.25 M(-4.2%)
$10.20 M(+11.4%)
Sep 2016
-
$9.16 M(-1.7%)
Jun 2016
-
$9.31 M(-12.0%)
Mar 2016
-
$10.58 M(-7.1%)
Dec 2015
$40.98 M(+99.9%)
$11.39 M(-2.2%)
Sep 2015
-
$11.65 M(+19.7%)
Jun 2015
-
$9.73 M(+18.6%)
Mar 2015
-
$8.21 M(+15.6%)
Dec 2014
$20.50 M(+66.2%)
$7.10 M(+44.6%)
Sep 2014
-
$4.91 M(+5.6%)
Jun 2014
-
$4.65 M(+21.2%)
Mar 2014
-
$3.84 M(-10.2%)
Dec 2013
$12.34 M(-28.7%)
$4.27 M(+27.0%)
Sep 2013
-
$3.37 M(+36.7%)
Jun 2013
-
$2.46 M(+9.9%)
Mar 2013
-
$2.24 M(-81.2%)
Dec 2012
$17.30 M(+191.8%)
$11.89 M(+547.4%)
Sep 2012
-
$1.84 M(+6.6%)
Jun 2012
-
$1.72 M(-7.1%)
Mar 2012
-
$1.85 M(-33.5%)
Dec 2011
$5.93 M(+60.3%)
$2.79 M(+220.1%)
Sep 2011
-
$871.00 K(+8.2%)
Jun 2011
-
$805.00 K(-45.0%)
Mar 2011
-
$1.46 M(+99.5%)
Dec 2010
$3.70 M(+1.1%)
$734.00 K(-11.7%)
Sep 2010
-
$830.80 K(-23.7%)
Jun 2010
-
$1.09 M(+3.8%)
Mar 2010
-
$1.05 M(+6.4%)
Dec 2009
$3.66 M
$986.10 K(+45.6%)
Sep 2009
-
$677.30 K(-23.0%)
DateAnnualQuarterly
Jun 2009
-
$879.60 K(-19.3%)
Mar 2009
-
$1.09 M(+18.4%)
Dec 2008
$7.32 M(-27.8%)
$920.10 K(-37.4%)
Sep 2008
-
$1.47 M(-18.4%)
Jun 2008
-
$1.80 M(-42.4%)
Mar 2008
-
$3.13 M(-2.8%)
Dec 2007
$10.14 M(+147.0%)
$3.22 M(+48.0%)
Sep 2007
-
$2.17 M(+18.9%)
Jun 2007
-
$1.83 M(-37.4%)
Mar 2007
-
$2.92 M(+38.1%)
Dec 2006
$4.10 M(+211.1%)
$2.12 M(+179.2%)
Sep 2006
-
$757.60 K(+5.8%)
Jun 2006
-
$716.20 K(+38.9%)
Mar 2006
-
$515.50 K(-24.1%)
Dec 2005
$1.32 M(-84.0%)
-
Mar 2003
-
$679.40 K(-19.6%)
Dec 2002
$8.26 M(-22.7%)
$845.20 K(-28.2%)
Sep 2002
-
$1.18 M(-62.1%)
Jun 2002
-
$3.10 M(-0.9%)
Mar 2002
-
$3.13 M(+4.0%)
Dec 2001
$10.68 M(+59.8%)
$3.01 M(+9.4%)
Sep 2001
-
$2.75 M(-10.9%)
Jun 2001
-
$3.09 M(-71.4%)
Mar 2001
-
$10.79 M(+438.6%)
Dec 2000
$6.68 M(+15.5%)
$2.00 M(+38.4%)
Sep 2000
-
$1.45 M(-10.0%)
Jun 2000
-
$1.61 M(-1.3%)
Mar 2000
-
$1.63 M(-3.4%)
Dec 1999
$5.79 M(+5.2%)
$1.69 M(+12.3%)
Sep 1999
-
$1.50 M(+7.1%)
Jun 1999
-
$1.40 M(+16.6%)
Mar 1999
-
$1.20 M(+20.1%)
Dec 1998
$5.50 M(-34.5%)
$1.00 M(-16.7%)
Sep 1998
-
$1.20 M(+9.1%)
Jun 1998
-
$1.10 M(-50.0%)
Mar 1998
-
$2.20 M(+633.3%)
Dec 1997
$8.40 M(+7.7%)
$300.00 K(-84.2%)
Sep 1997
-
$1.90 M(-44.1%)
Jun 1997
-
$3.40 M(+25.9%)
Mar 1997
-
$2.70 M(+22.7%)
Dec 1996
$7.80 M(+5.4%)
$2.20 M(0.0%)
Sep 1996
-
$2.20 M(+29.4%)
Jun 1996
-
$1.70 M(0.0%)
Mar 1996
-
$1.70 M(-10.5%)
Dec 1995
$7.40 M(+15.6%)
$1.90 M(-9.5%)
Sep 1995
-
$2.10 M(+425.0%)
Dec 1994
$6.40 M(+73.0%)
-
Mar 1994
-
$400.00 K(-63.6%)
Dec 1993
$3.70 M
$1.10 M(-26.7%)
Sep 1993
-
$1.50 M(+200.0%)
Jun 1993
-
$500.00 K(+25.0%)
Mar 1993
-
$400.00 K

FAQ

  • What is Synthetic Biologics annual total operating expenses?
  • What is the all time high annual operating expenses for Synthetic Biologics?
  • What is Synthetic Biologics annual operating expenses year-on-year change?
  • What is Synthetic Biologics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Synthetic Biologics?
  • What is Synthetic Biologics quarterly operating expenses year-on-year change?

What is Synthetic Biologics annual total operating expenses?

The current annual operating expenses of SYN is $14.27 M

What is the all time high annual operating expenses for Synthetic Biologics?

Synthetic Biologics all-time high annual total operating expenses is $40.98 M

What is Synthetic Biologics annual operating expenses year-on-year change?

Over the past year, SYN annual total operating expenses has changed by +$4.11 M (+40.49%)

What is Synthetic Biologics quarterly total operating expenses?

The current quarterly operating expenses of SYN is $4.99 M

What is the all time high quarterly operating expenses for Synthetic Biologics?

Synthetic Biologics all-time high quarterly total operating expenses is $11.89 M

What is Synthetic Biologics quarterly operating expenses year-on-year change?

Over the past year, SYN quarterly total operating expenses has changed by +$1.79 M (+55.93%)